← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Scienture Holdings, Inc. (SCNX) 10-Year Financial Performance & Capital Metrics

SCNX • • Industrial / General
HealthcareHealthcare ITRevenue Cycle ManagementClaims Processing & Payment Integrity
AboutTRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.Show more
  • Revenue $137K -90.0%
  • EBITDA -$15M -337.7%
  • Net Income $9M +150.8%
  • EPS (Diluted) 2.48 +133.1%
  • Gross Margin 4.39% +22.2%
  • EBITDA Margin -10719.65% -4268.5%
  • Operating Margin -10758.7% -3237.5%
  • Net Margin 6634.66% +607.1%
  • ROE 22.77% +100.6%
  • ROIC -24.61% +69.6%
  • Debt/Equity 0.04 -99.6%
  • Interest Coverage -11.01 -186.2%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Healthy 5Y average net margin of 1044.8%
  • ✓Trading at only 0.0x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 7 (bottom 7%)
  • ✗Sales declining 55.0% over 5 years
  • ✗Dividend payout exceeds 100% of earnings
  • ✗Shares diluted 53.4% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-21.28%
5Y-55.04%
3Y-76%
TTM-73.18%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM18.35%

EPS CAGR

10Y-
5Y-
3Y-
TTM86.75%

ROCE

10Y Avg-35.36%
5Y Avg-115.97%
3Y Avg-155.77%
Latest-30.03%

Peer Comparison

Claims Processing & Payment Integrity
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
PINCPremier, Inc.2.34B28.26128.45-10.86%-2.42%-1.59%13.64%0.18
SCNXScienture Holdings, Inc.21.25M0.520.21-89.98%-31.46%-24.86%0.04
MSPRMSP Recovery, Inc.950.43K0.07-0.00136.85%-73.28%-55.86%
CTEVClaritev Corporation496.76M30.06-0.29-3.21%-35.93%-183.57%54.05
TBRGTruBridge, Inc.326.3M21.74-15.750.95%1.59%30.92%3.99%1.04

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+2.91M2.48M2.93M3.83M7.44M17.12M9.89M10.25M1.36M136.64K
Revenue Growth %0.95%-0.15%0.18%0.31%0.94%1.3%-0.42%0.04%-0.87%-0.9%
Cost of Goods Sold+189.84K16.36K0449.05K2.57M11.42M5.14M4.73M1.31M130.64K
COGS % of Revenue0.07%0.01%-0.12%0.34%0.67%0.52%0.46%0.96%0.96%
Gross Profit+2.72M2.47M2.93M3.38M4.87M5.71M4.75M5.52M49.03K6K
Gross Margin %0.93%0.99%1%0.88%0.66%0.33%0.48%0.54%0.04%0.04%
Gross Profit Growth %1.58%-0.09%0.19%0.15%0.44%0.17%-0.17%0.16%-0.99%-0.88%
Operating Expenses+2.86M3.47M2.54M3.47M4.75M8.21M10.04M8.44M4.45M14.71M
OpEx % of Revenue0.98%1.4%0.87%0.91%0.64%0.48%1.02%0.82%3.26%107.63%
Selling, General & Admin2.86M3.34M1.41M3.47M4.38M7.49M7.54M6.57M4.35M12.05M
SG&A % of Revenue0.98%1.35%0.48%0.91%0.59%0.44%0.76%0.64%3.19%88.22%
Research & Development00863.32K949.95K0662.73K899.71K993.18K02.24M
R&D % of Revenue--0.29%0.25%-0.04%0.09%0.1%-16.37%
Other Operating Expenses0131.27K267.83K-949.95K368.52K63.25K1.6M875.25K100.28K416.31K
Operating Income+-137.07K-1.01M395.1K-87.62K125.22K-2.51M-5.29M-2.92M-4.4M-14.7M
Operating Margin %-0.05%-0.41%0.13%-0.02%0.02%-0.15%-0.54%-0.28%-3.22%-107.59%
Operating Income Growth %0.9%-6.35%1.39%-1.22%2.43%-21.02%-1.11%0.45%-0.51%-2.34%
EBITDA+-133.27K-1.02M446.04K66.58K219.96K-2.4M-5.15M-2.72M-3.35M-14.65M
EBITDA Margin %-0.05%-0.41%0.15%0.02%0.03%-0.14%-0.52%-0.27%-2.45%-107.2%
EBITDA Growth %0.91%-6.67%1.44%-0.85%2.3%-11.93%-1.14%0.47%-0.23%-3.38%
D&A (Non-Cash Add-back)3.8K00094.73K102.52K138.91K194.7K1.05M53.36K
EBIT-137.07K-1.02M446.04K66.58K-231.2K-2.51M-5.29M-2.07M-7.34M-17.44M
Net Interest Income+-119.51K-151.5K-157.06K-57.54K-53.23K-29.39K-23.59K-315.22K-1.14M-1.2M
Interest Income000000020.99K4.2K135.34K
Interest Expense119.51K151.5K157.06K57.54K53.23K29.39K23.59K336.21K1.14M1.34M
Other Income/Expense-119.51K-165.83K-106.11K96.65K-409.65K-29.39K-23.59K512.53K-4.09M-4.08M
Pretax Income+-256.58K-1.17M288.98K9.04K-284.43K-2.54M-5.32M-2.4M-8.48M-18.78M
Pretax Margin %-0.09%-0.47%0.1%0%-0.04%-0.15%-0.54%-0.23%-6.22%-137.43%
Income Tax+000000000-534.4K
Effective Tax Rate %4.35%2.35%1%1%1%1%1%1.44%2.1%-0.48%
Net Income+-1.12M-2.76M288.98K9.04K-284.43K-2.54M-5.32M-3.47M-17.84M9.07M
Net Margin %-0.38%-1.11%0.1%0%-0.04%-0.15%-0.54%-0.34%-13.08%66.35%
Net Income Growth %0.44%-1.47%1.1%-0.97%-32.47%-7.92%-1.1%0.35%-4.14%1.51%
Net Income (Continuing)-256.58K-1.17M288.98K9.04K-284.43K-2.54M-5.32M-2.4M-8.48M-18.24M
Discontinued Operations-860.6K-1.59M00000-1.51M-9.36M27.31M
Minority Interest0000000-420.27K00
EPS (Diluted)+-3.21-7.870.900.02-0.72-4.94-9.80-6.15-7.492.48
EPS Growth %0.47%-1.45%1.11%-0.97%-31.9%-5.86%-0.98%0.37%-0.22%1.33%
EPS (Basic)-3.21-7.870.900.03-0.72-4.94-9.80-6.15-23.352.69
Diluted Shares Outstanding347.95K350.5K378.74K388.35K395.27K513.71K542.45K564.86K2.38M3.65M
Basic Shares Outstanding347.95K350.5K355.06K358.38K395.27K513.71K542.45K564.86K764.06K3.38M
Dividend Payout Ratio---------1.64%

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+524.15K337.12K607.48K1.47M3.8M9.22M4.37M2.09M2.75M6.31M
Cash & Short-Term Investments78.71K14.68K183.91K869.56K2.87M5.92M3.12M1.09M314308.1K
Cash Only78.71K14.68K183.91K869.56K2.87M5.92M3.12M1.09M314308.1K
Short-Term Investments0000000000
Accounts Receivable354.74K299.11K319.47K433.63K792.05K1.89M978.97K629.92K2.52M5.45M
Days Sales Outstanding44.4643.9939.7841.3138.8840.3536.1322.43675.6814.56K
Inventory284.72K0079.97K56.76K1.26M56.28K65.52K9680
Days Inventory Outstanding547.42--658.0840.223.995.060.27-
Other Current Assets-279.57K8942K0000198.32K176.35K542.95K
Total Non-Current Assets+1.5M010K761.51K1.77M571.4K1.39M1.62M9.78M98.55M
Property, Plant & Equipment00015.01K932.7K549.77K1.33M1.12M198.72K218.93K
Fixed Asset Turnover---255.35x7.97x31.14x7.43x9.18x6.86x0.62x
Goodwill000725.97K725.97K000021.37M
Intangible Assets000000008.96M76.4M
Long-Term Investments0000000000
Other Non-Current Assets1.5M010K20.53K109.87K21.64K60.14K499.87K618.45K22.04K
Total Assets+2.03M337.12K617.48K2.23M5.57M9.79M5.77M3.71M12.53M104.85M
Asset Turnover1.44x7.36x4.75x1.72x1.33x1.75x1.72x2.76x0.11x0.00x
Asset Growth %0.66%-0.83%0.83%2.61%1.5%0.76%-0.41%-0.36%2.38%7.37%
Total Current Liabilities+1.76M1.47M525.36K860.37K520.82K842.24K926.03K2.15M11.56M7.91M
Accounts Payable220.35K236.85K106.08K400.54K334.61K256.83K477.03K527.98K1.46M2.9M
Days Payables Outstanding423.675.28K-325.5747.618.2133.8540.74406.158.1K
Short-Term Debt399.3K770.76K262.31K321.5K0225K0166.67K6.53M2.7M
Deferred Revenue (Current)0000010K05.13K00
Other Current Liabilities892.61K000000916.52K3.37M930.72K
Current Ratio0.30x0.23x1.16x1.70x7.30x10.95x4.72x0.98x0.24x0.80x
Quick Ratio0.14x0.23x1.16x1.61x7.19x9.46x4.66x0.94x0.24x0.80x
Cash Conversion Cycle168.21---219.27-0.6572.356.27-13.25269.81-
Total Non-Current Liabilities+010.59K404.05K522.55K910.46K271.31K1.07M1.22M434.2K17.87M
Long-Term Debt708.39K10.59K404.05K522.55K225K00333.33K25K612.27K
Capital Lease Obligations0000685.46K271.31K1.07M887.03K176.91K156.47K
Deferred Tax Liabilities00000000013.52M
Other Non-Current Liabilities-708.39K0000000232.3K3.58M
Total Liabilities1.76M1.49M929.41K1.38M1.43M1.11M2M3.37M11.99M25.78M
Total Debt+1.11M781.35K666.36K844.05K997.81K627.46K1.25M1.58M6.76M3.53M
Net Debt1.03M766.67K482.45K-25.5K-1.87M-5.29M-1.87M489.01K6.76M3.22M
Debt / Equity4.15x--1.00x0.24x0.07x0.33x4.62x12.47x0.04x
Debt / EBITDA--1.49x12.68x4.54x-----
Net Debt / EBITDA--1.08x-0.38x-8.52x-----
Interest Coverage-1.15x-6.65x2.52x-1.52x2.35x-85.29x-224.34x-8.67x-3.85x-11.01x
Total Equity+267.02K-1.15M-311.93K844.67K4.14M8.68M3.77M342.87K542.35K79.07M
Equity Growth %-0.6%-5.3%0.73%3.71%3.9%1.1%-0.57%-0.91%0.58%144.79%
Book Value per Share0.77-3.28-0.822.1810.4716.906.950.610.2321.64
Total Shareholders' Equity267.02K-1.15M-311.93K844.67K4.14M8.68M3.77M763.14K542.35K79.07M
Common Stock314316320556581826987
Retained Earnings-5.65M-8.41M-8.12M-8.11M-8.4M-10.93M-16.25M-19.72M-33.25M-39.04M
Treasury Stock0000000000
Accumulated OCI0000000000
Minority Interest0000000-420.27K00

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-1.97M-1.31M171.67K273.39K141.78K-2.21M-2.57M-1.56M-2.23M-14.27M
Operating CF Margin %-0.68%-0.53%0.06%0.07%0.02%-0.13%-0.26%-0.15%-1.63%-104.4%
Operating CF Growth %-0.85%0.33%1.13%0.59%-0.48%-16.62%-0.16%0.39%-0.42%-5.41%
Net Income-256.58K-1.17M288.98K9.04K-284.43K-2.54M-5.32M-2.4M-8.48M-18.24M
Depreciation & Amortization3.8K00094.73K102.52K138.91K194.7K1.05M53.36K
Stock-Based Compensation000001.36M181.16K254.11K00
Deferred Taxes0000000000
Other Non-Cash Items-1.58M-513.54K385.54K179.69K999.33K2.46M1.34M132.38K-305.4K6.53M
Working Capital Changes-136.87K373.23K-502.85K84.65K-667.86K-3.6M1.08M257.58K5.51M-2.6M
Change in Receivables-39.12K55.78K-20.35K-1.53K-369.92K-23.53K298.09K-505.32K-548.71K-2.93M
Change in Inventory-255.16K00-3.81K23.2K-2.42M825.13K-51.74K4.23M968
Change in Payables-67.8K16.5K-98.21K95.15K-148.66K-33.19K220.2K199.83K1.61M448.57K
Cash from Investing+0-78K0-265.28K-332.25K-37.51K-22.6K-427.85K-275.72K27.55M
Capital Expenditures000-15.01K-82.25K-37.51K-22.6K-450.85K0-12K
CapEx % of Revenue---0%0.01%0%0%0.04%0%0.09%
Acquisitions----------
Investments----------
Other Investing0-78K0000023K68.74K27.43M
Cash from Financing+1.36M1.17M-2.44K677.54K2.19M5.3M-208.18K-35.17K1.41M-12.98M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid000000000-14.86M
Share Repurchases----------
Other Financing951.67K714.4K2500166-694.25K16.82K-166.09K638.31K-1.25M
Net Change in Cash----------
Free Cash Flow+-1.97M-1.31M171.67K258.38K59.52K-2.25M-2.59M-1.56M-2.23M-14.28M
FCF Margin %-0.68%-0.53%0.06%0.07%0.01%-0.13%-0.26%-0.15%-1.63%-104.49%
FCF Growth %-0.85%0.33%1.13%0.51%-0.77%-38.84%-0.15%0.4%-0.42%-5.42%
FCF per Share-5.67-3.750.450.670.15-4.38-4.77-2.77-0.93-3.91
FCF Conversion (FCF/Net Income)1.77x0.48x0.59x30.25x-0.50x0.87x0.48x0.45x0.12x-1.57x
Interest Paid4.93K23.56K71.21K36.97K98.46K29.44K28.34K336.21K00
Taxes Paid0000000000

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)-238.85%--3.39%-11.41%-39.57%-85.4%-168.83%-4031.44%22.77%
Return on Invested Capital (ROIC)-16.33%-165.2%--13.28%6.09%-66.51%-150.26%-160.34%-81.03%-24.61%
Gross Margin93.48%99.34%100%88.28%65.5%33.33%47.99%53.85%3.6%4.39%
Net Margin-38.36%-111.21%9.86%0.24%-3.82%-14.81%-53.75%-33.87%-1308.34%6634.66%
Debt / Equity4.15x--1.00x0.24x0.07x0.33x4.62x12.47x0.04x
Interest Coverage-1.15x-6.65x2.52x-1.52x2.35x-85.29x-224.34x-8.67x-3.85x-11.01x
FCF Conversion1.77x0.48x0.59x30.25x-0.50x0.87x0.48x0.45x0.12x-1.57x
Revenue Growth94.66%-14.79%18.11%30.72%94.07%130.26%-42.24%3.65%-86.69%-89.98%

Revenue by Geography

2024
UNITED STATES136.64K
UNITED STATES Growth-

Frequently Asked Questions

Valuation & Price

Scienture Holdings, Inc. (SCNX) has a price-to-earnings (P/E) ratio of 0.2x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Scienture Holdings, Inc. (SCNX) reported $0.7M in revenue for fiscal year 2024.

Scienture Holdings, Inc. (SCNX) saw revenue decline by 90.0% over the past year.

Scienture Holdings, Inc. (SCNX) reported a net loss of $20.6M for fiscal year 2024.

Dividend & Returns

Yes, Scienture Holdings, Inc. (SCNX) pays a dividend with a yield of 100.00%. This makes it attractive for income-focused investors.

Scienture Holdings, Inc. (SCNX) has a return on equity (ROE) of 22.8%. This is excellent, indicating efficient use of shareholder capital.

Scienture Holdings, Inc. (SCNX) had negative free cash flow of $11.1M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.